Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glyphic Biotechnologies
New York, New York, USAglyphic.bio ↗
- Ownership
- Private
- Employees
- ~18
- Development stage
- Preclinical
01
Overview
Glyphic Biotechnologies has developed a next-generation single-molecule protein sequencing platform that enables the direct identification and quantification of proteins at scale. The company’s technology aims to surpass traditional methods like ELISA and mass spectrometry by allowing unbiased detection of proteins—including unknown biomarkers—in complex mixtures. Early-stage research includes monoclonal antibody development against drug-resistant bacterial pathogens. No clinical trial results are available yet; the company remains focused on technology/platform validation and early therapeutic applications.[2][5][7][8]
- Therapeutic areas
- OtherInfectious Diseases
- Modalities
- Protein sequencing technology (platform for proteomics)Monoclonal antibodies (in development for infectious disease)[8]
- Industry
- Biotech
02
Partnerships
Collaboration with MIT on glycomics/antibody engineering for infectious disease program[8]. No major pharma partnerships disclosed.
Beyond the preview
Go deeper on Glyphic Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glyphic Biotechnologies.